Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Where next for Darktrace shares after 33% nosedive?

Darktrace shares have collapsed once again after Thoma Bravo exits takeover talks, despite posting excellent full-year results.

darktrace Source: Bloomberg

Darktrace (LON: DARK) shares have been an investing rollercoaster ever since their Initial Public Offering in April 2021. Rocketing to 946p by 22 October last year, they then fell to a low of 293p on 1 July 2022.

The shares then rose to 544p by mid-August, and remained above the 500p support level as investors clung to news that Thoma Bravo was interested in a potential takeover.

But today Darktrace shares have again crashed, this time by 33% to 342p, as the US private equity giant has announced it has walked away from the talks.

However, it’s not all bad news.

Darktrace share price: FY2022 results

The Cambridge-based cyber security AI stock now boasts 7,437 customers across 110 countries, a 32.1% year-over-year growth in its customer base. And it’s increased its headcount to more than 2,000 employees across more than 30 offices worldwide.

Revenue increased by 45.7% year-over-year to £415 million, on a gross margin of 89.2%. Revenue growth was ‘across all geographic markets and customer sizes.’ And revenue has grown by similar percentages over the past three fiscal years.

Happily, non-adjusted EDITBA rose by a whopping 874% to £63.8 million, while free cash flow increased by 290% to £99.5 million.

And encouragingly, Darktrace delivered an operating profit of £7.6 million, compared to a £34.8 million loss in fiscal 2021. Annual recurring revenue (at constant currency rates) also rose, by 42.6% to £514.4 million. This represents a consistent trend: ARR rose by 45.3% in fiscal 2021, and 40.9% in fiscal 2020.

Darktrace argues that ‘we’ve turbo-charged our growth by adding ground-breaking products to our platform, including our new Prevent offerings. We have a proven business model, which is generating cash. Today’s results are yet another example of our strong performance.’

FTSE 250 Source: Bloomberg

Where next for Darktrace shares?

On the numbers alone, Darktrace appears to have a bright future. It has a $155 billion top-down total addressable market, and believes that there are currently 150,000 companies that could one day potentially adopt the Darktrace cyber-AI platform.

CEO Poppy Gustafsson enthuses that ‘today’s results are yet another example of our strong performance. Being listed on the London Stock Exchange is exactly where we want to be right now.’ And Darktrace is still on track for its 2023 guidance, after hiking its full-year profit margin forecast to 19.5% in July.

The company has benefitted from several external factors, including the rise of remote working and the Russia-Ukraine war, both of which have seen a spike in cyber-attacks and a corresponding increase in corporate investment in security software.

However, growth stocks like Darktrace are valued on far more than just financials. Its recent share price uplift had been sustained by Thoma Bravo. And the private equity firm now says ‘it does not intend to make an offer for Darktrace.’

Worse, under city takeover rules, it is prevented from returning with another offer within the next six months, unless under very specific criteria, such as a direct deal with the board, or a competing bidder entering the fray.

Thoma Bravo may believe the legal troubles plaguing Darktrace co-founder, and 12% share owner, Mike Lynch, outweigh the recent financial successes.

Lynch is appealing against a ‘vindictive’ extradition to the US, where he faces charges over the $11 billion sale of Autonomy to Hewlett-Packard in 2011. HP suffered a $9 billion writedown on Autonomy shortly after the sale, and the UK high court has already ruled that Lynch duped HP into the deal using accounting trickery.

Despite Lynch exiting day-to-day involvement in Darktrace earlier this year, the FTSE 250 company could find itself could face money laundering charges if the proceeds of the Autonomy sale are found to have been used to fund its rapid growth.

In addition, Darktrace has long been shorted by ShadowFall. Managing partner Matthew Earl makes the compelling argument that ‘since our first short in September 2021, Darktrace has been a significant contributor to the ShadowFall Fund...we see this morning’s announcement as supportive of our view, and continue to believe that there are numerous issues with Darktrace, including accounting, governance, and cultural concerns.’

This leaves Darktrace shares with a complex investment case. On the numbers alone, it appears an exceptional growth opportunity, especially after the share price crash.

But the unresolved legal problems could well see it fall further.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.